Comparative killing rates of fluoroquinolones and cell wall-active agents

被引:26
作者
Fung-Tomc, JC [1 ]
Gradelski, E [1 ]
Valera, L [1 ]
Kolek, B [1 ]
Bonner, DP [1 ]
机构
[1] Bristol Myers Squibb Co, Dept Microbiol 104, Wallingford, CT 06492 USA
关键词
D O I
10.1128/AAC.44.5.1377-1380.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Killing rates of fluoroquinolones, beta-lactams, and vancomycin were compared against Enterobacteriaceae, Staphylococcus aureus, pneumococci, streptococci, and Enterococcus faecalis. The times required for fluoroquinolones to decrease viability by 3 log(10) were 1.5 h for Enterobacteriaceae, 4 to 6 h for staphylococci, and greater than or equal to 6 h for streptococci and enterococci. Thus, the rate of killing by fluoroquinolones is organism group dependent; overall, they killed more rapidly than beta-lactams and vancomycin.
引用
收藏
页码:1377 / 1380
页数:4
相关论文
共 15 条
  • [1] [Anonymous], 1999, METHODS DETERMINING
  • [2] Bactericidal properties of moxifloxacin and post-antibiotic effect
    Boswell, FJ
    Andrews, JM
    Wise, R
    Dalhoff, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 : 43 - 49
  • [3] EFFICACY OF TEMAFLOXACIN IN EXPERIMENTAL STREPTOCOCCUS-ADJACENS ENDOCARDITIS AND AUTORADIOGRAPHIC DIFFUSION PATTERN OF [C-14] TEMAFLOXACIN IN CARDIAC VEGETATIONS
    CREMIEUX, AC
    SALEHMGHIR, A
    VALLOIS, JM
    MAZIERE, B
    MUFFATJOLY, M
    DEVINE, C
    BOUVET, A
    POCIDALO, JJ
    CARBON, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (10) : 2216 - 2221
  • [4] DEBBIA E, 1987, CHEMIOTERAPIA, V4, P319
  • [5] PARENTERAL SPARFLOXACIN COMPARED WITH CEFTRIAXONE IN TREATMENT OF EXPERIMENTAL ENDOCARDITIS DUE TO PENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT STREPTOCOCCI
    ENTENZA, JM
    BLATTER, M
    GLAUSER, MP
    MOREILLON, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) : 2683 - 2688
  • [6] Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis
    Entenza, JM
    Vouillamoz, J
    Glauser, MP
    Moreillon, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) : 77 - 84
  • [7] Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins
    FungTomc, JC
    Gradelski, E
    Huczko, E
    Dougherty, TJ
    Kessler, RE
    Bonner, DP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) : 1289 - 1293
  • [8] Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents
    Hoellman, DB
    Lin, GR
    Jacobs, MR
    Appelbaum, PC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (05) : 645 - 649
  • [9] Johnson C.C., 1996, ANTIBIOTIC LAB MED, V4th, P813
  • [10] ANTIBACTERIAL ACTIVITY OF A 1,8-NAPHTHYRIDINE QUINOLONE, PD-131628
    LEWIN, CS
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1992, 36 (05) : 353 - 357